Company news
Climb Bio, Inc. news in 2024
Climb Bio, Inc.'s news releases, calls and decks from 2024, newest first.
Climb Bio to be Added to the Nasdaq Biotechnology Index
December 18, 2024
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights
November 11, 2024
Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board
November 10, 2024
Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024
October 10, 2024
Decks in 2024
- Eliem Therapeutics — Merger or Acquisition (April 2024)
Merger or acquisition · 18 slides · Apr 11, 2024